thiophenes has been researched along with pulmicort in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bianchi, T; Braga, PC; Culici, M; Dal Sasso, M; Fonti, E; Guffanti, EE | 1 |
Belvisi, MG; Birrell, MA; Catley, M; De Alba, J; Haj-Yahia, S; Hardaker, E; McCluskie, K; Newton, R; Pun, KT; Savage, TJ; Shaw, RJ; Watts, CJ; Wong, S | 1 |
Belvisi, MG; Birrell, MA; Hardaker, E; Knowles, R; McCluskie, K | 1 |
Beckmann, N; Blé, FX; Cannet, C; Frossard, N; Gérard, C; Trifilieff, A; Zurbruegg, S | 1 |
4 other study(ies) available for thiophenes and pulmicort
Article | Year |
---|---|
A combination of budesonide and the SH-metabolite I of erdosteine acts synergistically in reducing chemiluminescence during human neutrophil respiratory burst.
Topics: Anti-Inflammatory Agents; Budesonide; Dose-Response Relationship, Drug; Drug Synergism; Humans; In Vitro Techniques; Luminescence; Neutrophils; Respiratory Burst; Thioglycolates; Thiophenes | 2005 |
Ikappa-B kinase-2 inhibitor blocks inflammation in human airway smooth muscle and a rat model of asthma.
Topics: Amides; Animals; Anti-Inflammatory Agents; Asthma; Budesonide; Cells, Cultured; Chemokine CCL11; Chemokines, CC; Dexamethasone; Disease Models, Animal; Drug Evaluation, Preclinical; Gene Expression; Granulocyte Colony-Stimulating Factor; Humans; I-kappa B Kinase; Inflammation; Interleukin-8; Muscle, Smooth; NF-kappa B; Rats; Respiratory System; Thiophenes | 2005 |
Utility of exhaled nitric oxide as a noninvasive biomarker of lung inflammation in a disease model.
Topics: Amides; Animals; Anti-Inflammatory Agents; Biomarkers; Budesonide; Disease Models, Animal; Exhalation; Lipopolysaccharides; Nitric Oxide; Pneumonia; Rats; Rats, Wistar; Respiratory System; Thiophenes | 2006 |
Activation of the lung S1P(1) receptor reduces allergen-induced plasma leakage in mice.
Topics: Administration, Intranasal; Allergens; Animals; Anti-Asthmatic Agents; Anti-Inflammatory Agents; beta-Alanine; Budesonide; Capillary Permeability; Dose-Response Relationship, Drug; Female; Fingolimod Hydrochloride; Immunologic Factors; Lung; Magnetic Resonance Imaging; Mice; Mice, Inbred C57BL; Mice, Knockout; Pneumonia; Propylene Glycols; Pulmonary Edema; Receptors, Lysosphingolipid; Sphingosine; Sphingosine-1-Phosphate Receptors; Thiophenes | 2009 |